Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides
We assessed the ability of several factors to increase the size of tumor-antigen-specific CD8(+) T cell responses elicited by vaccines incorporating peptides and CpG-containing oligodeoxynucleotides (CpG). Neither granulocyte-macrophage colony-stimulating factor (GM-CSF) nor an immunogenic MHC class...
| Publié dans: | Clinical immunology (Orlando, Fla.). - 1999. - 124(2007), 2 vom: 20. Aug., Seite 119-30 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , |
| Format: | Article |
| Langue: | English |
| Publié: |
2007
|
| Accès à la collection: | Clinical immunology (Orlando, Fla.) |
| Sujets: | Journal Article Research Support, N.I.H., Intramural Adjuvants, Immunologic CPG-oligonucleotide Cancer Vaccines Epitopes Interleukin-2 Oligodeoxyribonucleotides Peptide Fragments Vaccines, Subunit plus... |